Tag: Odonate Therapeutics

October 21, 2019 Off

Odonate Therapeutics enrolls patients with Metastatic Breast Cancerin in a Phase 3 study of Tesetaxel

Odonate Therapeutics on Monday announces completion of enrollment in CONTESSA, a Phase 3 Study of Tesetaxel in Patients with Metastatic…

April 25, 2019 Off

Odonate Therapeutics Announces Financial Results for the Three Months Ended March 31, 2019

By BusinessWire

SAN DIEGO–(BUSINESS WIRE)–Odonate Therapeutics, Inc. (NASDAQ: ODT), a pharmaceutical company dedicated to the development of best-in-class therapeutics that improve and…